Oncology
Gastroenteropancreatic Neuroendocrine Tumors
Conference Reporter® in GEP-NETS to Cover Key Topics Being Presented at the 2026 SNMMI Annual Meeting
Overview
Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in GEP-NETs presented at the 2026 SNMMI Annual Meeting.
VIEW THE TOPICS:
- AI in Imaging-Guided Therapy: Clinical and Translational Advances
- Next-Wave Radiopharmaceuticals and Theranostic Frontiers
- Real World Insights and Patient Perspectives on Precision Radiopharmaceuticals
- Toward Optimizing the Therapeutic Index of PRRT
This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the Society of Nuclear Medicine & Molecular Imaging.
2026 SNMMI Annual Meeting
May 30– June 2, 2026
Los Angeles, CA
Explore More in Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors
The Multimodal Treatment of Gastroenteropancreatic Neuroendocrine Tumors and Available Data on Combinatorial Strategies
Gastroenteropancreatic Neuroendocrine Tumors
Expert Roundtables Podcast: Individualizing Therapy for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors
Treating Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors of Higher Biological Aggressiveness
Gastroenteropancreatic Neuroendocrine Tumors